PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 57 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 2,536,600 | $2,892,000 | 0.36% |
| HARBOURVEST PARTNERS LLC | 440,627 | $502,000 | 0.24% |
| Bain Capital Public Equity Management II, LLC | 765,986 | $873,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 165,565 | $189,000 | 0.05% |
| RBF Capital, LLC | 166,078 | $189,000 | 0.02% |
| WINTON GROUP Ltd | 680,119 | $775,000 | 0.02% |
| 9258 Wealth Management, LLC | 25,095 | $33,000 | 0.02% |
| Lehman & Derafelo Financial Resources LLC | 11,000 | $13,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 120,000 | $137,000 | 0.00% |
| HAP Trading, LLC | 36,700 | $26,000 | 0.00% |